162 related articles for article (PubMed ID: 6771004)
1. Comparative pharmacology of pentamethylmelamine and hexamethylmelamine in mice.
Morimoto M; Green D; Rahman A; Goldin A; Schein PS
Cancer Res; 1980 Aug; 40(8 Pt 1):2762-7. PubMed ID: 6771004
[No Abstract] [Full Text] [Related]
2. Pharmacokinetics of hexamethylmelamine and pentamethylmelamine in mice.
Broggini M; Colombo T; D'Incalci M; Donnelli MG; Gescher A; Garattini S
Cancer Treat Rep; 1981; 65(7-8):669-72. PubMed ID: 6788370
[TBL] [Abstract][Full Text] [Related]
3. In vitro cytotoxicity of the methylmelamines.
Rutty CJ; Abel G
Chem Biol Interact; 1980 Feb; 29(2):235-46. PubMed ID: 6766359
[TBL] [Abstract][Full Text] [Related]
4. Analogues of hexamethylmelamine. The anti-neoplastic activity of derivatives with enhanced water solubility.
Cumber AJ; Ross WC
Chem Biol Interact; 1977 Jun; 17(3):349-57. PubMed ID: 407012
[TBL] [Abstract][Full Text] [Related]
5. [Structure-activity relationship of hexamethylmelamine derivatives].
Su YZ; Pan QC; Sun MZ; Ren YF
Zhongguo Yao Li Xue Bao; 1983 Dec; 4(4):276-80. PubMed ID: 6230876
[No Abstract] [Full Text] [Related]
6. In vitro studies with hexamethylmelamine.
Rutty CJ; Connors TA
Biochem Pharmacol; 1977 Dec; 26(24):2385-91. PubMed ID: 413551
[No Abstract] [Full Text] [Related]
7. Comparison of DNA damage by methylmelamines and formaldehyde.
Ross WE; McMillan DR; Ross CF
J Natl Cancer Inst; 1981 Jul; 67(1):217-21. PubMed ID: 6788992
[TBL] [Abstract][Full Text] [Related]
8. In vitro cytotoxicity of hexamethylmelamine (HMM) and its derivatives.
Dubois J; Arnould R; Abikhalil F; Hanocq M; Atassi G; Ghanem G; Libert A; Lejeune FJ
Anticancer Res; 1990; 10(3):827-32. PubMed ID: 2114821
[TBL] [Abstract][Full Text] [Related]
9. Regression of human lung tumor xenografts induced by water-soluble analogs of hexamethylmelamine.
Connors TA; Cumber AJ; Ross WC; Clarke SA; Mitchley BC
Cancer Treat Rep; 1977 Aug; 61(5):927-8. PubMed ID: 408005
[No Abstract] [Full Text] [Related]
10. Hexamethylmelamine and pentamethylmelamine tissue distribution in M5076/73A ovarian cancer-bearing mice.
Broggini M; Rossi C; Colombo T; D'Incalci M
Cancer Treat Rep; 1982 Jan; 66(1):127-33. PubMed ID: 6796267
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of action and pharmacology studies with DTIC (NSC-45388).
Loo TL; Housholder GE; Gerulath AH; Saunders PH; Farquhar D
Cancer Treat Rep; 1976 Feb; 60(2):149-52. PubMed ID: 1260772
[No Abstract] [Full Text] [Related]
12. Pharmacology of pentamethylmelamine in humans.
Benvenuto JA; Stewart DJ; Benjamin RS; Loo TL
Cancer Res; 1981 Feb; 41(2):566-9. PubMed ID: 6778609
[TBL] [Abstract][Full Text] [Related]
13. Phase I study of pentamethylmelamine.
Goldberg RS; Griffin JP; McSherry JW; Krakoff IH
Cancer Treat Rep; 1980; 64(12):1319-22. PubMed ID: 6781746
[TBL] [Abstract][Full Text] [Related]
14. Metabolic activation of hexamethylmelamine and pentamethylmelamine by liver microsomal preparations.
Ames MM; Sanders ME; Tiede WS
Life Sci; 1981 Oct; 29(15):1591-8. PubMed ID: 6795407
[No Abstract] [Full Text] [Related]
15. Studies of the mode of action of antitumour triazenes and triazines-V. The correlation of the in vitro cytotoxicity and in vivo antitumour activity of hexamethylmelamine analogues with their metabolism.
Ross D; Langdon SP; Gescher A; Stevens MF
Biochem Pharmacol; 1984 Apr; 33(7):1131-6. PubMed ID: 6424683
[TBL] [Abstract][Full Text] [Related]
16. [Molecular basis of the relation between the cytotoxic effect of antineoplastic compounds and the cell cycle phase].
Belousova AK
Vopr Onkol; 1972; 18(8):88-96. PubMed ID: 4348595
[No Abstract] [Full Text] [Related]
17. Effect of phenobarbital pretreatment on the metabolism and antitumor activity of hexamethylmelamine.
Paolini A; D'Incalci M
Cancer Treat Rep; 1986 Apr; 70(4):513-6. PubMed ID: 3084083
[TBL] [Abstract][Full Text] [Related]
18. Some effects of 1, 3-bis(2-chloroethyl)-1-nitrosourea upon the synthesis of protein and nucleic acids in vivo and in vitro.
Wheeler GP; Bowdon BJ
Cancer Res; 1965 Nov; 25(10):1770-8. PubMed ID: 5859203
[No Abstract] [Full Text] [Related]
19. Randomized phase II trial of hexamethylmelamine versus pentamethylmelamine in carcinoma of the bilharzial bladder.
Gad-el-Mawla N; Ziegler JL; Hamza R; Elserafi M; Khaled H
Cancer Treat Rep; 1984 May; 68(5):793-4. PubMed ID: 6426792
[No Abstract] [Full Text] [Related]
20. Uptake and metabolism of hexamethylmelamine and pentamethylmelamine by L5178Y lymphoblasts in vitro.
Begleiter A; Grover J; Goldenberg GJ
Cancer Res; 1980 Dec; 40(12):4489-94. PubMed ID: 6777039
[No Abstract] [Full Text] [Related]
[Next] [New Search]
